JPS57193413A - Medicament for alleviating hypercalcemia - Google Patents

Medicament for alleviating hypercalcemia

Info

Publication number
JPS57193413A
JPS57193413A JP7779181A JP7779181A JPS57193413A JP S57193413 A JPS57193413 A JP S57193413A JP 7779181 A JP7779181 A JP 7779181A JP 7779181 A JP7779181 A JP 7779181A JP S57193413 A JPS57193413 A JP S57193413A
Authority
JP
Japan
Prior art keywords
hypercalcemia
alleviating
medicament
medicated
hydroxycholecalciferol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP7779181A
Other languages
Japanese (ja)
Other versions
JPS6221331B2 (en
Inventor
Yuji Maeda
Takami Fujii
Yasuhiko Kobayashi
Kenichi Saito
Tadaaki Kato
Chikao Yoshikumi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kureha Corp
Original Assignee
Kureha Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kureha Corp filed Critical Kureha Corp
Priority to JP7779181A priority Critical patent/JPS57193413A/en
Publication of JPS57193413A publication Critical patent/JPS57193413A/en
Publication of JPS6221331B2 publication Critical patent/JPS6221331B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PURPOSE: A medicament for alleviating hypercalcemia capable of being medicated orally, having improved durability of effect, comprising 24-hydroxycholecalciferol as an active ingredient.
CONSTITUTION: 24-Hydroxycholecalciferol as an active ingredient is pharmaceutically manufactured into a peroral or parenteral drug or a drug to be medicated to the rectum, and used as a medicament for alleviating hypercalcemia. Hypercalcemia is a disease of abnormally high calcium content of the serum, for example, often accompanying malignant tumor, vitamin D poisoning, sarcoidosis, hyperparathyroidism, etc. A daily dose per adult is about 1×10-2W1×10-4μg, and preferably medicated orally.
COPYRIGHT: (C)1982,JPO&Japio
JP7779181A 1981-05-22 1981-05-22 Medicament for alleviating hypercalcemia Granted JPS57193413A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP7779181A JPS57193413A (en) 1981-05-22 1981-05-22 Medicament for alleviating hypercalcemia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7779181A JPS57193413A (en) 1981-05-22 1981-05-22 Medicament for alleviating hypercalcemia

Publications (2)

Publication Number Publication Date
JPS57193413A true JPS57193413A (en) 1982-11-27
JPS6221331B2 JPS6221331B2 (en) 1987-05-12

Family

ID=13643801

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7779181A Granted JPS57193413A (en) 1981-05-22 1981-05-22 Medicament for alleviating hypercalcemia

Country Status (1)

Country Link
JP (1) JPS57193413A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5946978A (en) * 1997-11-13 1999-09-07 Shimano Inc. Cable adjustment device

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5946978A (en) * 1997-11-13 1999-09-07 Shimano Inc. Cable adjustment device

Also Published As

Publication number Publication date
JPS6221331B2 (en) 1987-05-12

Similar Documents

Publication Publication Date Title
EP0552256A4 (en)
EP0130779A3 (en) Pharmaceutical composition suitable for intestinal administration
ATE234602T1 (en) ADMINISTRATION FORM FOR THE DELIVERY OF INCREASING DOSES OF ACTIVE INGREDIENTS
FI103951B1 (en) system of prevention
IS1694B (en) Medicinal product for administration to oral animals containing proton pump blockers
YU48583B (en) Process for preparation of the formulation in the form of pill for oral dosage
RU93036959A (en) FREE SOLUBLE MEDICATION WITH SLOW-UP ACTION OF BIOLOGICALLY ACTIVE SUBSTANCES, ASSIGNED FOR RECEPTION INSIDE, THE METHOD OF ITS MANUFACTURE
NZ229518A (en) Pharmaceutical dosage form for the medication of fish: method of administration and (prophylactic) treatment
IE791806L (en) Gastroprotective mollusc extract
AU1935788A (en) A process for producing an administration and/or dosage form for medically active ingredients of drugs
SE8306367L (en) ANTIDIURETICALLY EFFECTIVE PHARMACEUTICAL PREPARATION
AU2793989A (en) Method for preparing a solid sustained release form of a functionally active composition and the dosage form so obtained
CA2038744A1 (en) Pharmaceutical composition containing slightly water-soluble drug
JPS5234935A (en) Medicinal composition
IE42950L (en) X-ray contrast preparations
Bolli et al. Clonidine in menopausal flushing: a double-blind trial
JPS57188520A (en) Antihyperkalemia
HUP9901303A2 (en) A pharmaceutical composition for the treatment of autoimmune diseases
JPS57193413A (en) Medicament for alleviating hypercalcemia
EP0271151A3 (en) Azumolene dosage form
JPS5551019A (en) Drug containing alllee or 133zz7*88dehydroo retine acid and manufacture thereof
JPS6416721A (en) Antioxidant
JPS643123A (en) Remedy for skin inflammation
JPS577422A (en) Crocosmia aurea "plach"
JPS5626819A (en) Preventive for hypoimmunity